LONDON BROKER RATINGS: JPMorgan raises Diploma, Barclays cuts Unite
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
(Alliance News) - GSK PLC on Monday reported two positive regulatory developments for its treatments of hepatitis and rectal cancer. Read More
(Alliance News) - Stock prices in London opened treading water on Monday, as investors await AI major Nvidia's interim results, and the start of the Jackson Hole symposium, later this week. Read More
(Alliance News) - The UK Treasury has enlisted an expert to review how business rates are calculated for pubs and hotels and make recommendations for reform of the system. Read More
(Alliance News) - The FTSE 100 was called slightly higher on Monday, following news of US President Donald Trump's intention to wage a "crushing" financial operation against Iran. Read More
(Alliance News) - Stocks in London are set to open essentially flat on Monday, in light of the US' latest wave of economic sanctions against Iran, and ahead of a busy week for global earnings including half-year results from Nvidia. Read More
(Alliance News) - British Prime Minister Andy Burnham will visit Kyiv on Monday on his first international visit since taking office last month, his office said, as Ukraine marks its 35th independence anniversary. Read More
(Alliance News) - UK Prime Minister Andy Burnham is set to give mayors new powers to take control of local planning decisions and greenlight large-scale developments in proposals to be unveiled next week. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News: Read More
CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - On Thursday, announced that the first clinical site for its phase 2 study of irinotecan ChemoSeed for the treatment of glioblastoma has now been formally activated and patient recruitment has started. CRISM says formal site activation is "a significant milestone" for ChemoSeed's clinical development programme. It enables the clinical team to start identifying, screening and enrolling eligible patients into the study. Read More
(Alliance News) - Aminex PLC on Friday said its subsidiary Ndovu Resources Ltd issued a notice of dispute to ARA Petroleum Tanzania Ltd and its parent company The Zubair Corporation LLC. Read More
(Alliance News) - The FTSE 100 ended the week on a positive note on Friday as data showed the UK private sector speeded up in August and a soaring gold price supported miners. Read More
(Alliance News) - Corero Network Security PLC on Friday announced artificial intelligence-augmented cloud-assist for SmartWall ONE. Read More
(Alliance News) - Metals One PLC said on Friday that it has finalised the phase one plan to restart the Barbrook gold mine in South Africa, with first gold concentrate production expected within six months. Read More